Cargando…
Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization
Background and Objectives: Corneal neovasculariziation (CNV) is a serious vision-threatening complication; however, all therapeutics have their clinical limitations. The aim of this study is to investigate the efficacy of topical rivoceranib compared with topical bevacizumab in a murine model of cor...
Autores principales: | Yoon, Hyeon Jeong, Woo, Je Moon, Ji, Yong Sok, Yoon, Kyung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915418/ https://www.ncbi.nlm.nih.gov/pubmed/31703332 http://dx.doi.org/10.3390/medicina55110729 |
Ejemplares similares
-
Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization
por: Kim, E Seul, et al.
Publicado: (2021) -
Efficacy of Topical Bevacizumab in High-Risk Corneal Transplant Survival
por: Bhatti, Nasir, et al.
Publicado: (2013) -
Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
por: Goktas, Sertan, et al.
Publicado: (2014) -
Topical Timolol Inhibits Corneal Neovascularization in Rabbits
por: KASIRI, Ali, et al.
Publicado: (2017) -
The Effect of Bevacizumab on Corneal Neovascularization in Rabbits
por: Kim, Wung-Jae, et al.
Publicado: (2010)